Corticosteroid therapy for patients hospitalized with community-acquired pneumonia : a systematic review
Abstract
Introduction: Pneumonia is an inflammation of the lung parenchyma in the distal terminal bronchioles, which includes the respiratory bronchioles and alveoli. Corticosteroids are routinely used for severe pneumonia symptoms. Numerous studies on adjuvant corticosteroids for community-acquired pneumonia (CAP) have yielded equivocal results. Several systematic reviews and meta-analyses have studied the efficacy of corticosteroids in treating CAP.
The aim: This article showed about corticosteroid therapy for patients hospitalized with community-acquired pneumonia (CAP).
Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020, this study was able to show that it met all of the requirements. So, the experts were able to make sure that the study was as up-to-date as it was possible to be. For this search approach, publications that came out between 2013 and 2023 were taken into account. Several different online reference sources, like Pubmed and SagePub, were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: The PubMed database yielded a total of 423 articles in response to our search query, while the search conducted on SagePub retrieved 491 articles. The search run for the last year of 2013 generated a total of 223 articles from PubMed and 212 articles from SagePub. Ultimately, a cumulative sum of…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.